Good day and welcome to the Bioventus third quarter, 2024 earnings conference call. (Operator Instructions) I would now like to turn the conference over to Dave Crawford. Please go ahead.
Q3 2024 Earnings Call Transcript November 4, 2024 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $-0.06. Operator: Good afternoon, and welcome to Castle ...
Accel Entertainment, Inc. ("Accel" or the "Company"), a leading distributed gaming operator, today announced that it has completed the acquisition of 85% of the ownership interests of Toucan Gaming, ...
About Fortis Fortis is a well-diversified leader in the North American regulated electric and gas utility industry with 2023 revenue of $12 billion and total assets of $70 billion as at September 30, ...
Thank you for joining us today. Earlier today, CareDx released financial results for the quarter ... This call will also include a discussion of certain certain financial measures that are not ...
Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its 2024 third quarter results.“Texture Healthful ...
Record quarterly revenue of $279 million, up 125% YoY Record auto insurance quarterly revenue, up 664% YoY; Strong demand continues Record home services ...
AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home ...
Total revenues of $365.1 million in Q3 2024 compared to $359.7 million in Q2 2024Net income of $28.2 million, or $0.95 per diluted share, in Q3 2024 compared to net income of $28.2 million, or $0.96 ...